Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Organizations
Organizations
Cellectis
Products 1 to 1 of 1
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
TALEN
by
Cellectis
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
+
France
Country of distribution:
USA
+
France
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
17,400,000 EUR
Funding types:
Shareholder Investment
Industry:
Health
+
Multipurpose
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
CLLS, ALCLS
(NASDAQ, EPA)
Value chain stage:
Platform
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
